Metsera, a clinical-stage biotech company focusing on obesity treatment, has recently gone public and started to attract favorable analyst ratings from Wall Street firms, showcasing significant potential for share price growth.
Tracking over the time
Alex Harring
02/25/2025 12:00:00 AM
Business & Finance

198 views
Happiness 😊